Pegfilgrastim biosimilar (Megalabs)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NamePegfilgrastim biosimilar (Megalabs)
Drug Alias NamePegfilgrastim生物仿制药Pegfilgrastim生物类似药
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUruguay
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMegalabs
China Registration ClassN/A

Develop Information

Active CompaniesMegalabs
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A